Pliant Therapeutics Cash from Financing (TTM) Trends

Pliant Therapeutics Inc (PLRX)

12.51 +0.32 (+2.63%) USD | NASDAQ | Apr 19, 16:00

12.51 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	274.40M
September 30, 2023	274.47M
June 30, 2023	490.07M
March 31, 2023	500.33M
December 31, 2022	226.85M
September 30, 2022	227.09M
June 30, 2022	11.24M
March 31, 2022	1.004M
December 31, 2021	2.527M

Date	Value
September 30, 2021	2.248M
June 30, 2021	-0.566M
March 31, 2021	162.88M
December 31, 2020	213.21M
September 30, 2020	259.81M
June 30, 2020	261.78M
March 31, 2020	97.37M
December 31, 2019	45.54M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.566M

Minimum

Jun 2021

500.33M

Maximum

Mar 2023

179.43M

Average

213.21M

Median

Dec 2020

Cash from Financing (TTM) Benchmarks